The promise of AI in regulatory isn’t fewer experts. It’s giving experts more time for the work that actually requires their judgment: reviewing evidence, finding gaps, applying context and advising the business. AI should scale expertise, not replace it. hubs.li/Q04z3d_c0

Rimsys Impact Surveys let MedTech teams align questions, participants, and workflows with their SOPs so assessments stay consistent without losing context. Regulatory changes don’t all follow the same path. See how we support coordinated change control: hubs.li/Q04yLJLk0

An impact assessment doesn’t end with a decision. Regulatory teams need to see who owns the response and what happens next. Rimsys Impact Surveys help assign responsibility, coordinate teams, and track follow-up work. Explore Impact Surveys: hubs.li/Q04yLH6d0

Regulatory changes don’t all follow the same path. Rimsys Impact Surveys let MedTech teams align questions, participants, and workflows with their SOPs so assessments stay consistent without losing context. See how we support coordinated change control: hubs.li/Q04ytqYM0

Fast regulatory answers are not enough. A defensible answer needs evidence: 📖 the right regulation, guidance, or law 🌎 the right product designation and market 👩‍💻 expert review, with uncertainty made clear Read out blog to understand better: hubs.li/Q04ylDrh0

An impact assessment should answer 4 questions: What is affected? Who needs to respond? What action is required? How will completion be shown? Rimsys Impact Surveys help MedTech teams bring structure to every assessment. Read here to learn more: hubs.li/Q04ygln-0

A regulatory or product change is only the start. The real work is understanding what it affects, who needs to review it, and what action comes next. Rimsys Impact Surveys help MedTech regulatory teams coordinate assessments and document decisions. hubs.li/Q04y6J760

Today is the last day at RAPS! If you’re looking to reduce manual work, connect regulatory data, or bring greater visibility to your global strategy, come say hello at Booth 712 and get your own Reggie duck too! #RAPS #MedTech #RegulatoryAffairs #RegulatoryOperations #AI

We’re set up and ready at RAPS! Stop by the Rimsys booth 712 to see how medtech teams can: Bring regulatory information into one connected platform, Turn market-entry strategy into action, and use AI to plan smarter and execute with confidence. #RAPSConvergence #RIMSoftware

Visit us at Booth 712! If market-entry planning is still a slow, market-by-market process in your organization, come talk to us! Our new Market Access AI-native global market planning platform will be just the thing you are looking for! #RAPSConvergence #MarketAccess

Today, we’re proud to announce Rimsys Market Access! It's an AI-native global market planning platform built to help medtech regulatory and commercial teams decide whether, when, and how to enter a market before committing. #MarketAccess #MedTech #RegulatoryAffairs #MarketEntry

Take our free quiz using the link below ⬇️ hubs.li/Q04vm-bZ0

We’ve been working on something new at Rimsys that brings greater clarity to one of MedTech’s earliest—and most consequential—regulatory decisions. Going to RAPS Convergence? Come see what’s next from Rimsys and visit us at booth 712. #RIM #HumanInTheLoop #RAPSConvergence

Do you know where your organization stands with RIM & AI Maturity? 🤔 If not, read our "RIM & AI Maturity in MedTech: Executive Guide to Modernization Success" We'll be at RAPS Convergence, booth #712, stop by and chat! hubs.li/Q04vgTp_0 #RAPSConvergence #RIM #RIMSYS_AI

The biggest barrier to AI in medtech isn't the technology - it's trust. AI changes the equation but not because AI replaces regulatory expertise. It changes what a regulatory team CAN be: not a bottleneck that slows expansion, but a strategic function that accelerates it.

See why Philips Healthcare selected Rimsys to modernize its regulatory operations and scale active product registrations by more than 20x. Read our case study here: hubs.li/Q04tVxWh0 #MedicalDevice #RIMSoftware